Revenue
2018
2019
2020
2021
2022
2023
2024
2025
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $40.5M | $32.3M | $78.1M | $19.7M | $25.5M | $90.7M | $20.5M | $31.9M | $13.7M | $6.1M | — | — |
| Research & development | $90.0M | $199.2M | $177.7M | $175.0M | $142.5M | $158.0M | $96.9M | $90.7M | $83.2M | $57.0M | $18.8M | $5.1M |
| Operating expenses | $200.5M | $283.5M | $247.3M | $245.7M | $218.7M | $225.6M | $161.5M | $145.7M | $133.7M | $103.2M | $36.9M | $12.7M |
| Operating income | −$160.0M | −$251.2M | −$169.2M | −$225.9M | −$193.1M | −$134.8M | −$140.9M | −$113.7M | −$119.9M | −$97.2M | −$35.3M | −$12.7M |
| Net income | −$160.1M | −$237.1M | −$153.2M | −$220.4M | −$192.5M | −$116.0M | −$133.7M | −$110.0M | −$120.3M | −$97.2M | −$72.9M | −$13.7M |
| Basic EPSper diluted share | -$1.80 | -$2.88 | -$2.02 | -$3.21 | -$2.85 | -$1.98 | -$2.68 | -$2.33 | -$2.98 | -$3.02 | -$28.55 | -$12.46 |
| Diluted EPSper diluted share | -$1.80 | -$2.88 | -$2.02 | -$3.21 | -$2.85 | -$1.98 | -$2.68 | -$2.33 | -$2.98 | -$3.02 | -$28.55 | -$12.46 |
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 3, 2026Form 4 · 10b5-1 | Parison AmySVP, Chief Financial Officer | SellCommon Stock | 464 | $2.70 | $1.3K | 15.0K |
| Jun 3, 2026Form 4 · 10b5-1 | O'Neill Gilmore NeilCEO | SellCommon Stock | 15.4K | $2.70 | $41.5K | 248.3K |
| Jun 3, 2026Form 4 · 10b5-1 | Burkly LindaEVP, CHIEF SCIENTIFIC OFFICER | SellCommon Stock | 731 | $2.70 | $2.0K | 67.3K |
| Mar 3, 2026Form 4 · 10b5-1 | O'Neill Gilmore NeilCEO | SellCommon Stock | 5.4K | $2.02 | $10.9K | 263.7K |
| Mar 3, 2026Form 4 · 10b5-1 | Parison AmySVP, Chief Financial Officer | SellCommon Stock | 474 | $2.02 | $957.48 | 15.4K |